Research advances on renoprotective mechanism of SGLT-2 inhibitors in non-diabetic kidney disease
Sodium-glucose linked transporter (SGLT-2) inhibitors are the most emerging glucose-lowering agents. Predominantly expressed in kidney, SGLT-2 is mainly distributed in upper part of proximal tubule. Mainly responsible for a reabsorption of filtered glucose, it accounts for over 80%-90% of glucose re...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Editorial Department of Journal of Clinical Nephrology,
2023-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|